# GPR55 Allosteric Antagonist Discovery

> **Computational Drug Discovery Pipeline for Novel GPR55 Antagonists**

[![Phase](https://img.shields.io/badge/Phase-3%20Complete-green)](docs/PHASE_3_COMPLETE.md)
[![HTVS](https://img.shields.io/badge/HTVS-Complete-success)]()
[![Target](https://img.shields.io/badge/Target-GPR55-blue)](docs/GPR55_INTRODUCTION.md)
[![License](https://img.shields.io/badge/License-MIT-yellow)](LICENSE)

---

## ğŸ¯ Project Overview

This project aims to discover novel antagonists for **GPR55** (G protein-coupled receptor 55), an atypical cannabinoid receptor implicated in cancer progression, inflammation, and metabolic disorders.

### Key Highlights
- **35,000+ compounds** screened across **3 binding sites**
- **Top hit: -12.3 kcal/mol** (2.84 kcal/mol better than AM251 control)
- **9 novel candidates** selected for MD validation
- **3 pan-site binders** discovered (bind all 3 sites)

---

## ğŸ“Š Pipeline Workflow

```mermaid
flowchart TD
    subgraph PREP["ğŸ“¦ PREPARATION"]
        A[35,000 Compounds<br/>ChEMBL + PubChem] --> B[Lipinski Filter<br/>Rule of 5]
        B --> C[10,940 Drug-like<br/>Compounds]
    end
    
    subgraph HTVS["ğŸ”¬ HIGH-THROUGHPUT VIRTUAL SCREENING"]
        C --> D[Stage 1: HTVS<br/>exh=8, modes=1]
        D --> E[3,279 Hits<br/>Top 10% per target]
        E --> F[Stage 2: Precision<br/>exh=64, modes=15]
        F --> G[373 Validated<br/>Dockings]
    end
    
    subgraph SELECT["ğŸ¯ SELECTION"]
        G --> H[Top 75 Hits<br/>25 per target]
        H --> I[9 Novel + 3 Controls<br/>for MD]
    end
    
    subgraph NEXT["ğŸ”® NEXT PHASE"]
        I --> J[ADMET Filtering]
        J --> K[MD Simulations<br/>150 ns Ã— 12]
        K --> L[MM/GBSA<br/>Binding Energy]
    end
    
    style A fill:#e0f2fe
    style C fill:#bbf7d0
    style G fill:#bbf7d0
    style I fill:#fef08a
    style L fill:#fecaca
```

---

## ğŸ§¬ Target Sites

Three validated binding sites on GPR55:

| Site | Location | Type | Best Hit | AM251 |
|------|----------|------|----------|-------|
| **P0** | Orthosteric (TM bundle) | Competitive | **-12.3** | -9.46 |
| **P3** | Allosteric (ECL region) | Non-competitive | **-8.5** | -7.70 |
| **Interface** | GPR55-GÎ± contact | PPI disruption | **-9.6** | -6.27 |

---

## ğŸ† Top Hits

### Best Candidates by Target

| Rank | Compound | Target | Affinity | vs AM251 |
|------|----------|--------|----------|----------|
| 1 | compound_11569386 | P0 | **-12.3** | +2.84 better |
| 2 | compound_124138019 | P0 | -11.4 | +1.94 better |
| 3 | compound_73952742 | P0 | -11.3 | +1.84 better |
| 4 | CHEMBL432162 | Interface | **-9.6** | +3.33 better |
| 5 | compound_92261630 | Interface | -9.1 | +2.83 better |
| 6 | compound_3992081 | P3 | **-8.5** | +0.80 better |

### Pan-Site Binders (Novel Finding)

**3 compounds bind ALL 3 target sites:**

| Compound | P0 | Interface | P3 |
|----------|----|-----------|----|
| compound_73952742 | -11.3 | -8.0 | -7.3 |
| compound_69204715 | -10.8 | -8.5 | -7.7 |
| compound_16947356 | -10.3 | -8.1 | -7.9 |

---

## ğŸ“ˆ Current Progress

| Phase | Description | Status |
|-------|-------------|--------|
| Phase 0 | Target Identification | âœ… Complete |
| Phase 1 | Protocol Validation (AM251) | âœ… Complete |
| Phase 2 | HTVS Screening | âœ… **Complete** |
| Phase 3 | Hit Selection & Analysis | âœ… **Complete** |
| Phase 4 | ADMET Profiling | ğŸ”„ Next |
| Phase 5 | MD Simulations (150 ns Ã— 12) | â¬œ Pending |
| Phase 6 | Binding Energy (MM/GBSA) | â¬œ Pending |

---

## ğŸ› ï¸ Technologies

| Category | Tools |
|----------|-------|
| **Docking** | AutoDock Vina 1.2.5 |
| **Cheminformatics** | RDKit, Open Babel |
| **Visualization** | PyMOL, UCSF Chimera |
| **MD Simulations** | GROMACS 2021 |
| **Compute** | Google Cloud VM (8-core) |

---

## ğŸ“ Repository Structure

```
â”œâ”€â”€ docs/                    # Project documentation
â”œâ”€â”€ scripts/                 # Docking and analysis scripts
â”‚   â”œâ”€â”€ colab/              # Colab notebook scripts
â”‚   â”œâ”€â”€ converters/         # Format conversion utilities
â”‚   â””â”€â”€ vm/                 # VM docking scripts
â”œâ”€â”€ config/                 # Docking configuration files
â”œâ”€â”€ results/                # Docking results
â”‚   â”œâ”€â”€ htvs_top75/        # Top 75 hit PDBQT files
â”‚   â”œâ”€â”€ stage3_results.csv # Complete results table
â”‚   â””â”€â”€ control_validation/ # AM251 control results
â”œâ”€â”€ figures/                # Visualizations & renders
â””â”€â”€ notebooks/              # Analysis notebooks
```

---

## ğŸ“– Key Documentation

- [GPR55 Introduction](docs/GPR55_INTRODUCTION.md) - Target background
- [Phase 0-1 Complete](docs/PHASE_0_1_COMPLETED.md) - Validation results
- [Target Coordinates](docs/TARGET_COORDINATES.md) - Binding site definitions

---

## ğŸ“š References

1. Eberhardt, J., et al. (2021). AutoDock Vina 1.2.0. *J. Chem. Inf. Model.* DOI: 10.1021/acs.jcim.1c00203
2. Lauckner, J.E., et al. (2008). GPR55 is a cannabinoid receptor. *PNAS* 105(7):2699-704
3. PDB 9IYA - GPR55-G protein complex structure (2025)

---

## ğŸ“œ License

This project is licensed under the MIT License - see [LICENSE](LICENSE) for details.

---

## ğŸ‘¤ Author

**Ayush** - [GitHub](https://github.com/Aayush-ob)

---

*Part of Bioinformatics Major Project | Timeline: Nov 2025 - Jun 2026*
